(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Turnover | 13.63%1.04B | 57.93%2.16B | 48.09%912.62M | 35.01%1.37B | --616.27M | 150.89%1.01B | --403.97M |
Operating income | 13.63%1.04B | 57.93%2.16B | 48.09%912.62M | 35.01%1.37B | 616.27M | 150.89%1.01B | 403.97M |
Cost of sales | -8.76%-1.07B | -52.65%-2.31B | -41.51%-983.31M | -20.31%-1.51B | ---694.87M | -153.66%-1.26B | ---496.19M |
Operating expenses | -8.76%-1.07B | -52.65%-2.31B | -41.51%-983.31M | -20.31%-1.51B | -694.87M | -153.66%-1.26B | -496.19M |
Gross profit | 54.10%-32.45M | -3.11%-150.45M | 10.06%-70.69M | 40.47%-145.91M | -78.59M | -165.80%-245.12M | -92.22M |
Selling expenses | 21.66%-85.88M | 5.39%-218.9M | 0.59%-109.62M | 12.59%-231.35M | ---110.27M | -72.58%-264.67M | ---153.36M |
Administrative expenses | 12.83%-63.4M | -45.15%-154.98M | -51.56%-72.73M | -6.92%-106.77M | ---47.99M | -86.38%-99.86M | ---53.58M |
Research and development expenses | -27.50%-73.52M | -12.85%-118.94M | -18.40%-57.67M | 9.62%-105.4M | ---48.71M | -169.46%-116.62M | ---43.28M |
Impairment and provision | -125.25%-3.89M | 43.59%-2.2M | -11.56%-1.73M | -347.82%-3.91M | ---1.55M | 82.81%-872K | ---5.07M |
-Other impairment is provision | -125.25%-3.89M | 43.59%-2.2M | -11.56%-1.73M | -347.82%-3.91M | ---1.55M | 82.81%-872K | ---5.07M |
Special items of operating profit | 16.56%3.24M | 62.80%51.61M | -60.38%2.78M | -27.39%31.7M | --7.03M | -12.69%43.66M | --50.01M |
Operating profit | 17.36%-255.89M | -5.74%-593.85M | -10.56%-309.64M | 17.83%-561.64M | -280.08M | -129.74%-683.48M | -297.5M |
Financing cost | 30.22%-905K | 0.95%-2.62M | 8.47%-1.3M | -129.17%-2.64M | ---1.42M | 32.31%-1.15M | ---1.7M |
Special items of earning before tax | -117.12%-74.84M | -54.11%-96.33M | -67.41%-34.47M | ---62.5M | ---20.59M | ---- | ---- |
Earning before tax | 3.99%-331.63M | -10.53%-692.79M | -14.34%-345.41M | 8.45%-626.78M | -302.09M | -128.82%-684.63M | -299.2M |
After-tax profit from continuing operations | 3.99%-331.63M | -10.53%-692.79M | -14.34%-345.41M | 8.45%-626.78M | -302.09M | -128.82%-684.63M | -299.2M |
Earning after tax | 3.99%-331.63M | -10.53%-692.79M | -14.34%-345.41M | 8.45%-626.78M | -302.09M | -128.82%-684.63M | -299.2M |
Profit attributable to shareholders | 3.99%-331.63M | -10.53%-692.79M | -14.34%-345.41M | 8.45%-626.78M | -302.09M | -128.82%-684.63M | -299.2M |
Basic earnings per share | 4.43%-3.67 | -10.49%-7.69 | -14.29%-3.84 | 8.54%-6.96 | -3.36 | -129.22%-7.61 | -3.32 |
Diluted earnings per share | 4.43%-3.67 | -10.49%-7.69 | -14.29%-3.84 | 8.54%-6.96 | -3.36 | -129.22%-7.61 | -3.32 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data